Title

Summary

•Chronic hepatitis C can be found in 30% of all HIV-patients

•HCV/HIV coinfected patients show a faster progression to cirrhosis and increased liver-related mortality

•With availability of pegylated interferon Hepatitis C specific treatment options should be considered before onset of immunodeficiency in HIV-coinfected patients

•HAART should not be withheld in coinfected patients

•